UFC Middleweight Oskar Piechota Accepts 22-Month USADA Suspension

UFC middleweight Oskar Piechota has accepted a 22-month suspension from USADA after an anti-doping violation.

USADA announced the sanction in a statement on Wednesday:

Piechota, 31, tested positive for growth hormone releasing peptide 2 (GHRP-2 or pralmorelin) and GHRP-2 (1-3) free acid, a metabolite of GHRP-2, as the result of a urine sample collected on September 25, 2020. GHRP-2 is a Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.

Piechota received a reduction to the default two-year sanction based on his Full and Complete Cooperation. His 22-month period of ineligibility began on September 25, 2020, the date his positive sample was collected.

Piechota won’t be eligible to return to active competition until July 2022. The 31-year-old Pole is winless in his last four UFC appearances. Most recently, a technical knockou defeat to Marc-Andre Barriault at UFC on ESPN 11 was overturned to a no contest after Barriault tested positive for a banned substance. Piechota is 2-3 with one no contest in UFC competition and 11-3-1 as a professional overall.